These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 6444955

  • 1. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC, Meunier PJ, Alexandre CM, Vignon EP.
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [Abstract] [Full Text] [Related]

  • 2. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P, Chapuy MC, Vignon E, Briançon D, Charhon S, Meunier PJ.
    Nouv Presse Med; 1982 Apr 24; 11(19):1471-4. PubMed ID: 6210878
    [Abstract] [Full Text] [Related]

  • 3. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE, Siris ES, Jacobs TP.
    Bone; 1987 Apr 24; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [Abstract] [Full Text] [Related]

  • 4. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma.
    Siris ES, Sherman WH, Baquiran DC, Schlatterer JP, Osserman EF, Canfield RE.
    N Engl J Med; 1980 Feb 07; 302(6):310-5. PubMed ID: 6444241
    [Abstract] [Full Text] [Related]

  • 5. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
    Jacobs TP, Siris ES, Bilezikian JP, Baquiran DC, Shane E, Canfield RE.
    Ann Intern Med; 1981 Mar 07; 94(3):312-6. PubMed ID: 6452846
    [Abstract] [Full Text] [Related]

  • 6. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES, Hyman GA, Canfield RE.
    Am J Med; 1983 Mar 07; 74(3):401-6. PubMed ID: 6219577
    [Abstract] [Full Text] [Related]

  • 7. Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
    Attardo-Parrinello G, Merlini G, Pavesi F, Crema F, Fiorentini ML, Ascari E.
    Arch Intern Med; 1987 Sep 07; 147(9):1629-33. PubMed ID: 2957971
    [Abstract] [Full Text] [Related]

  • 8. Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
    Conte N, Di Virgilio R, Roiter I, Caberlotto L.
    Tumori; 1985 Feb 28; 71(1):51-4. PubMed ID: 3157251
    [Abstract] [Full Text] [Related]

  • 9. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E, Jacobs TP, Siris ES, Steinberg SF, Stoddart K, Canfield RE, Bilezikian JP.
    Am J Med; 1982 Jun 28; 72(6):939-44. PubMed ID: 6211978
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Laine H.
    Cancer Treat Rep; 1984 Apr 28; 68(4):655-7. PubMed ID: 6231989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of hypercalcemia of tumoral origin with two diphosphonates].
    Jung A, van Ouwenaller C, Chantraine A, Courvoisier B.
    Schweiz Med Wochenschr; 1980 Nov 29; 110(48):1822-4. PubMed ID: 6792698
    [Abstract] [Full Text] [Related]

  • 16. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH.
    Biomed Pharmacother; 1988 Nov 29; 42(2):111-6. PubMed ID: 2971403
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC, Charhon SA, Meunier PJ.
    Metab Bone Dis Relat Res; 1983 Nov 29; 4(6):325-8. PubMed ID: 6229683
    [Abstract] [Full Text] [Related]

  • 19. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
    Paterson AD, Kanis JA, Cameron EC, Douglas DL, Beard DJ, Preston FE, Russell RG.
    Br J Haematol; 1983 May 29; 54(1):121-32. PubMed ID: 6221750
    [Abstract] [Full Text] [Related]

  • 20. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M, Beuzeboc P, Mauriac L, Barbet N, Frenay M, Monnier A, Pion JM, Switsers O, Misset JL, Assadourian S, Bessa E.
    Bull Cancer; 2001 Jul 29; 88(7):701-7. PubMed ID: 11495824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.